by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
ATLANTA, Sept. 14, 2016 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced its financial results for the fourth quarter and 2016 fiscal year ended June 30, 2016, and also provided an update on recent corporate and clinical developments....
by GlobeNewsWire | Sep 14, 2016 | Globe Newswire
SANTA CLARA, Calif., Sept. 14, 2016 (GLOBE NEWSWIRE) — Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company, announced today that its miraSmooth™ treatment was featured in the September 6th episode of “The Rachael Ray Show”, an award-winning and...
by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
DEVON, Pa., Sept. 13, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the...
by GlobeNewsWire | Sep 13, 2016 | Globe Newswire
BRANFORD, Conn., Sept. 13, 2016 (GLOBE NEWSWIRE) — BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced that the U. S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BXCL101 for the treatment of...
by GlobeNewsWire | Sep 13, 2016 | Feature Box, Featured, FP, Globe Newswire
Reprocessing service for varicose vein ablation catheter continues to gain customers nearly five years after launch Excellent record of safety and reliability Reprocessing lowers costs and reduces medical waste for U.S. vein clinics MINNEAPOLIS, Sept. 13, 2016 (GLOBE...